2025 Buick Envista Sport Touring
1.2 L • I3 • FWD • AT
KL47LBEP5SB086642
Sales history: 1
• $9,400Highlights
Condition
Run and drive
Seller
Insurance • State Farm Insurance
Key included
Yes
Docs
Good
History
1 record
Drive
1.2 L • I3 • FWD • AT
Odometer
988 mi ≈ 1,590 km
Primary damage
Side
Docs
NJ • Salvage
Extra
Auction
VIN
KL47LBEP5SB086642
Lot number
68891055
Copart
Sale status
Sold
Seller type
Insurance
Seller
State Farm Insurance
Location
Glassboro East, NJ
Description
Fuel type
Gasoline
Body color
Gray
Body type
SUV
Trim
Sport Touring
All sales final. Always run reports before bid
Sharing our own experience
Over the years, we’ve learned all the ins and outs of car importing — so you don’t have to.
How it works
A full step-by-step guide that walks you through the entire process — from signing up to receiving your car at your doorstep. Clear & beginner-friendly.
Purchase process
Knowledge base
A structured library of content covering every major topic in car importing — including terms, rules, key concepts, and important real-world nuances.
Import encyclopedia
Watch & learn
Short, practical videos packed with tips from real experience. No fluff, no theory — just what actually helps when importing a car from the US to Poland.
Watch guides
Popular Buick models
2025 Buick Envista Sport Touring • 1.2 L • I3 • FWD • Automatic • Copart Lot: 68891055 • VIN: KL47LBEP5SB086642
Find out more about this 2025 Buick Envista Sport Touring, available at the Copart salvage car auction as lot 68891055 in Glassboro East, NJ. This car has Side main damage. It is listed with Run and drive start condition code. Odometer shows 988 mi. This Gray Buick Envista SUV is equipped with Gasoline 1.2 L engine, FWD drivetrain, Automatic transmission. Check the vehicle history report for KL47LBEP5SB086642 to access detailed information on accidents, ownership, and title status. Review pricing trends and uncover hidden issues before placing your bid.
We use cookies to improve your experience and analyze site usage, as outlined in our Privacy policy. By closing this message or continuing to browse, you consent to their use.
